Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 29419-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- INCENP antibody
- Antibody type
- Polyclonal
- Description
- INCENP antibody (Cat. #29419-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human and has been validated for the following applications: WB, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Nucleosome interaction of the CPC secures centromeric chromatin integrity and chromosome segregation fidelity.
The RNA-stability-independent role of the RNA m(6)A reader YTHDF2 in promoting protein translation to confer tumor chemotherapy resistance.
Identification of TAP1 as a T-cell related therapeutic target in gastric cancer by mediating oxalipliatin-related synergistic enhancement of immunotherapy.
CCDC69 maintains genome integrity by regulating KIF2C/MCAK depolymerase activity and the stability of the chromosomal passenger complex.
The anaphase-promoting complex controls a ubiquitination-phosphoprotein axis in chromatin during neurodevelopment.
Gireesh A, Abad MA, Nozawa RS, Sotelo-Parrilla P, Dury LC, Likhodeeva M, Wear M, Spanos C, Peralta CC, Rappsilber J, Hopfner KP, Wilson MD, Vanderlinden W, Hirota T, Jeyaprakash AA
The EMBO journal 2025 Nov;44(22):6556-6597
The EMBO journal 2025 Nov;44(22):6556-6597
The RNA-stability-independent role of the RNA m(6)A reader YTHDF2 in promoting protein translation to confer tumor chemotherapy resistance.
Liu T, Yang D, Wei Q, Wang Y, Tian L, Liu X, Yang Y, Luo Q, Xu J, Liu Y, Yang C, Zuo X, Luo F, Luo X, Zhao H, Li L, Xu J, Yu J, Ma S, Yu J, Yi P
Molecular cell 2025 Jun 19;85(12):2320-2336.e9
Molecular cell 2025 Jun 19;85(12):2320-2336.e9
Identification of TAP1 as a T-cell related therapeutic target in gastric cancer by mediating oxalipliatin-related synergistic enhancement of immunotherapy.
Zhao Y, Liu Z, Deng K, Qu H, Zhang Q, Zhou P, Yang M, Yang X, Wang H, Li R, Xia J
International immunopharmacology 2024 May 10;132:111998
International immunopharmacology 2024 May 10;132:111998
CCDC69 maintains genome integrity by regulating KIF2C/MCAK depolymerase activity and the stability of the chromosomal passenger complex.
Fesquet D, Rabeharivelo G, van Dijk J, Prigent C, Morin N, Rouquier S
Scientific reports 2024 Dec 5;14(1):30401
Scientific reports 2024 Dec 5;14(1):30401
The anaphase-promoting complex controls a ubiquitination-phosphoprotein axis in chromatin during neurodevelopment.
Ledvin L, Gassaway BM, Tawil J, Urso O, Pizzo D, Welsh KA, Bolhuis DL, Fisher D, Bonni A, Gygi SP, Brown NG, Ferguson CJ
Developmental cell 2023 Dec 4;58(23):2666-2683.e9
Developmental cell 2023 Dec 4;58(23):2666-2683.e9
No comments: Submit comment
No validations: Submit validation data